Philips Appoints Deborah DiSanzo as New CEO of the Healthcare Sector

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHI) announced the appointment of Deborah DiSanzo as Chief Executive Officer of Philips Healthcare and member of its Executive Committee, with effect from May 1, 2012. Mrs. DiSanzo will succeed Steve Rusckowski, who will leave the company per April 30, 2012.

"I'm happy that with Deborah DiSanzo we have found a strong leader for Healthcare within our own organization," said Frans van Houten, Chief Executive Officer of Philips. "Deborah has a proven track record within the healthcare industry and has grown the Patient Care and Clinical Informatics (PCCI) business to become the global market leader in patient monitoring."

"At the same time I thank Steve for his long-term contribution to Philips," Van Houten continued. "During his leadership of our Healthcare sector, Philips strengthened its position in the industry in growth geographies and through targeted acquisitions such as in Home Healthcare. Steve has been a great supporter and I regret to see him go. I wish him all the best in his new role."

"I look very much forward to become a member of the Philips Executive Committee and CEO of Philips Healthcare," said Mrs. DiSanzo. "We have a strong foundation and are well positioned to grasp growth opportunities for Philips Healthcare in all phases of the care cycle, driven by our strong and meaningful innovation."

"After more than ten years with Philips, I am ready to take on a new challenge in the healthcare industry," said Steve Rusckowski, Chief Executive Officer of Philips Healthcare. "I'm proud of all the people within the Healthcare sector that grew our business into one of the leading medical device players. I am pleased that Deborah DiSanzo is succeeding me and I’m confident that Philips Healthcare under her leadership will further strengthen its position."

Mrs. DiSanzo, born in 1960 in the United States, joined Philips in 2001 when Philips acquired Agilent's Healthcare Solutions Group. She became General Manager of Patient Monitoring in June 2006 and CEO of Healthcare Informatics and Patient Monitoring in June 2008. In April 2010, Deborah DiSanzo became CEO of Patient Care and Clinical Informatics (PCCI).

Mr. Rusckowski, born in 1957 in the United States, joined Philips in 2001 when Philips acquired Agilent's Healthcare Solutions Group. In November 2006, he became Chief Executive Officer of Philips Healthcare.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...